He promoted ESI in NSL, then NSL in ESI and ACW in NEU all within hours. Those are just the ones I noticed. Seems a bit dodge that you're allowed to write 3/4 about one stock then spend the last quarter talking about another stock to try and get people interested.
Each to their own I guess.
FDA Grants Orphan Drug Designation, page-26
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.38 |
Change
-0.820(5.77%) |
Mkt cap ! $1.742B | |||
| Open | High | Low | Value | Volume |
| $13.88 | $13.91 | $13.29 | $6.540M | 483.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 387 | $13.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.38 | 379 | 7 |
View Market Depth
| Last trade - 13.13pm 08/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |